Inspire Medical Systems (NYSE:INSP) Target Raised by SVB Leerink LLC to $110.00

0
22

Inspire Medical Systems stock has undergone multiple analysts rating changes in the recent past.  Inspire Medical Systems stock Target Raised by   SVB Leerink LLC on 6/29/2020. In a note to investors, the firm issued a new target price of $110.00. The analysts previously had $85.00 target price. SVB Leerink LLC’s price target would indicate a potential upside of 30.18% from the stock’s previous close.

Shares of Inspire Medical Systems traded down -$0.32 on Monday, reaching $84.18. 225871 shares of the stock traded hands, compared to its average volume of 417749. Shares of were trading at $84.18 on Monday. The firm’s 50 day moving average is $80.23 and its 200 day moving average is 71.12.Inspire Medical Systems  has a 12 month low of $82.77 and a 12 month high of $99.26. While on yearly highs and lows, Inspire Medical Systems today has traded high as $86.30 and has touched $82.77 on the downward trend.

Inspire Medical Systems Earnings and What to expect: 

Inspire Medical Systems last posted its quarterly earnings data on May 5th, 2020. The reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.57) by $0.10. The business earned $21.30 million during the quarter, compared to analysts’ expectations of $21.35 million. Its revenue was up 30.7% on a year-over-year basis. Inspire Medical Systems has generated ($1.40) earnings per share over the last year. Inspire Medical Systems has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, August 4th, 2020 based off prior year’s report dates.

Earnings for Inspire Medical Systems are expected to grow in the coming year, from ($3.11) to ($2.19) per share. The P/E ratio of Inspire Medical Systems is -49.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Inspire Medical Systems is -49.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Inspire Medical Systems has a P/B Ratio of 14.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 6.60%
  • On 6/23/2020 CFO Richard Buchholz Sell 12,000 at average share price of $97.25 which equates to $1,167,000.00 in money value.
  • On 6/23/2020 VP Steven Jandrich Sell 1,000 at average price of  $96.39 with total value of : Not Data Available
  • On 6/15/2020 Director Casey M Tansey Sell 100,000 at average price of  $84.04 with total value of : $8,404,000.00
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Inspire Medical Systems

  • 6/18/2020 – Inspire Medical Systems had its price target raised by analysts at Piper Sandler from $81.00 to $98.00. They now have an “overweight” rating on the stock. ()
  • 5/26/2020 – Inspire Medical Systems had its price target raised by analysts at Wells Fargo & Co from $81.00 to $95.00. They now have an “overweight” rating on the stock. ()
  • 5/18/2020 – Inspire Medical Systems is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $90.00 price target on the stock. ()
  • 5/7/2020 – Inspire Medical Systems was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. ()
  • See More Analyst Rating at: RATING

Other rating updates by SVB Leerink LLC: 

  • 6/29/2020 – Intersect ENT had its price target lowered by analysts at SVB Leerink LLC from $15.00 to $14.00. They now have a “market perform” rating on the stock. ()
  • 6/29/2020 – Nuance Communications is now covered by analysts at SVB Leerink LLC. They set an “outperform” rating and a $31.00 price target on the stock. ()
  • 6/26/2020 – Translate Bio had its price target raised by analysts at SVB Leerink LLC from $21.00 to $30.00. They now have an “outperform” rating on the stock. ()
  • 6/26/2020 – Acceleron Pharma had its price target raised by analysts at SVB Leerink LLC from $127.00 to $132.00. They now have an “outperform” rating on the stock. ()
  • See More Analyst Rating at: RATING

Inspire Medical Systems (NYSE:INSP) Moving Average Technical Analysis

5 day Moving Average is $90.03 And 5 day price change is -11.46 (-11.93%)  with average volume for 5 day average is 729,976. While technical analysis for average 20 days shows significant difference, 20 day moving average is  88.7 and 20 day price change is 1.29 (0.0154) and average 20 day moving volume is 436,139. 50 day moving average is 80.23  and 50 day price change is 8.39 ( 0.11)  and with average volume for 50 days is : 393,222. 200 day moving average is 71.12  and 200 day price change is 21.96 (0.3503)  and with average volume for 200 days is : 348,589.

See More Analyst Rating at: RATING